Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542111 | SCV000626712 | likely benign | Glycogen storage disease type III | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002528305 | SCV003737122 | uncertain significance | Inborn genetic diseases | 2022-10-27 | criteria provided, single submitter | clinical testing | The c.2930G>A (p.R977Q) alteration is located in exon 22 (coding exon 21) of the AGL gene. This alteration results from a G to A substitution at nucleotide position 2930, causing the arginine (R) at amino acid position 977 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Center for Genomics, |
RCV000542111 | SCV003919837 | uncertain significance | Glycogen storage disease type III | 2021-03-30 | criteria provided, single submitter | clinical testing | AGL NM_000642.2 exon 22 p.Arg977Gln (c.2930G>A): This variant has not been reported in the literature but is present in 0.1% (22/19952) of East Asian alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/1-100356893-G-A). This variant is present in ClinVar (Variation ID:456478). Evolutionary conservation suggests that this variant may impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. |
Natera, |
RCV000542111 | SCV002094509 | uncertain significance | Glycogen storage disease type III | 2019-10-28 | no assertion criteria provided | clinical testing |